Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles
View ORCID ProfileBetty M Tijms, Ellen M Vromen, Olav Mjaavatten, View ORCID ProfileHenne Holstege, Lianne M Reus, Sven van der Lee, Kirsten EJ Wesenhagen, View ORCID ProfileLuigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccoló Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, View ORCID ProfileFrederik Barkhof, Yolande AL Pijnenburg, Wiesje M van der Flier, Charlotte E Teunissen, Frode Berven, Pieter Jelle Visser
doi: https://doi.org/10.1101/2023.05.10.23289793
Betty M Tijms
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Ellen M Vromen
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Olav Mjaavatten
3PROBE, department of biomedicine, University of Bergen, Bergen, Norway
Henne Holstege
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
8Amsterdam Neuroscience, Neuroimaging, Amsterdam, the Netherlands
Lianne M Reus
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
5Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA
Sven van der Lee
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
6Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
Kirsten EJ Wesenhagen
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Luigi Lorenzini
7Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
8Amsterdam Neuroscience, Neuroimaging, Amsterdam, the Netherlands
Lisa Vermunt
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
9Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam UMC location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
Vikram Venkatraghavan
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Niccoló Tesi
6Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
10Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands
Jori Tomassen
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Anouk den Braber
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Julie Goossens
11ADx NeuroSciences, Ghent, Belgium
Eugeen Vanmechelen
11ADx NeuroSciences, Ghent, Belgium
Frederik Barkhof
5Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA
6Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
12Institutes of Neurology and Healthcare Engineering, University College London, London, UK
Yolande AL Pijnenburg
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Wiesje M van der Flier
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
Charlotte E Teunissen
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
9Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam UMC location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
Frode Berven
3PROBE, department of biomedicine, University of Bergen, Bergen, Norway
Pieter Jelle Visser
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands
13Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands
14Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden
Article usage
Posted May 11, 2023.
Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven van der Lee, Kirsten EJ Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccoló Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande AL Pijnenburg, Wiesje M van der Flier, Charlotte E Teunissen, Frode Berven, Pieter Jelle Visser
medRxiv 2023.05.10.23289793; doi: https://doi.org/10.1101/2023.05.10.23289793
Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles
Betty M Tijms, Ellen M Vromen, Olav Mjaavatten, Henne Holstege, Lianne M Reus, Sven van der Lee, Kirsten EJ Wesenhagen, Luigi Lorenzini, Lisa Vermunt, Vikram Venkatraghavan, Niccoló Tesi, Jori Tomassen, Anouk den Braber, Julie Goossens, Eugeen Vanmechelen, Frederik Barkhof, Yolande AL Pijnenburg, Wiesje M van der Flier, Charlotte E Teunissen, Frode Berven, Pieter Jelle Visser
medRxiv 2023.05.10.23289793; doi: https://doi.org/10.1101/2023.05.10.23289793
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2915)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12709)
- Forensic Medicine (12)
- Gastroenterology (826)
- Genetic and Genomic Medicine (4566)
- Geriatric Medicine (414)
- Health Economics (726)
- Health Informatics (2912)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4331)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (497)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6914)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (484)
- Toxicology (60)
- Transplantation (210)
- Urology (178)